Clinical Trial Update: Durvalumab in HIV-1 Patients With Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating durvalumab in HIV-1 infected patients with solid tumors has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Solid Tumors

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: HIV, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-06-24